Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases
PACIRA (NASDAQ: PCRX) Delayed: 24.48 -0.43 (1.73%)
Previous Close $24.91    52 Week High $80.25 
Open $25.11    52 Week Low $30.25 
Day High $25.20    P/E N/A 
Day Low $24.45    EPS $-2.08 
Volume 393,790